vs
BioNTech SE（BNTX）与赛莱默（XYL）财务数据对比。点击上方公司名可切换其他公司
赛莱默的季度营收约是BioNTech SE的1.4倍（$2.1B vs $1.5B），赛莱默净利率更高（8.9% vs -1.9%，领先10.8%）
BioNTech SE是总部位于德国美因茨的跨国生物技术企业，专注于免疫疗法及疫苗研发工作，核心研究方向覆盖肿瘤、传染性疾病等医疗领域，相关技术处于全球生物医药行业领先水平。
该文本为植物学对木质部的定义说明，并非赛莱默公司（Xylem Inc.）的企业业务介绍。Xylem Inc.是一家专注于水技术与解决方案的全球企业，提供水务基础设施、水环境治理等相关设备与服务。
BNTX vs XYL — 直观对比
营收规模更大
XYL
是对方的1.4倍
$1.5B
净利率更高
XYL
高出10.8%
-1.9%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $2.1B |
| 净利润 | $-28.7M | $189.0M |
| 毛利率 | — | 37.8% |
| 营业利润率 | -3.1% | 11.5% |
| 净利率 | -1.9% | 8.9% |
| 营收同比 | — | 2.7% |
| 净利润同比 | — | 13.2% |
| 每股收益（稀释后） | — | $0.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNTXXYL
| Q1 26 | — | $2.1B | ||
| Q4 25 | — | $2.4B | ||
| Q3 25 | $1.5B | $2.3B | ||
| Q2 25 | $260.8M | $2.3B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | — | $2.2B |
净利润BNTXXYL
| Q1 26 | — | $189.0M | ||
| Q4 25 | — | $335.0M | ||
| Q3 25 | $-28.7M | $227.0M | ||
| Q2 25 | $-386.6M | $226.0M | ||
| Q1 25 | — | $169.0M | ||
| Q4 24 | — | $326.0M | ||
| Q3 24 | $198.1M | $217.0M | ||
| Q2 24 | — | $194.0M |
毛利率BNTXXYL
| Q1 26 | — | 37.8% | ||
| Q4 25 | — | 38.9% | ||
| Q3 25 | — | 38.9% | ||
| Q2 25 | — | 38.8% | ||
| Q1 25 | — | 37.1% | ||
| Q4 24 | — | 38.0% | ||
| Q3 24 | — | 37.3% | ||
| Q2 24 | — | 37.8% |
营业利润率BNTXXYL
| Q1 26 | — | 11.5% | ||
| Q4 25 | — | 14.7% | ||
| Q3 25 | -3.1% | 14.7% | ||
| Q2 25 | -192.1% | 13.3% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | 0.8% | 13.3% | ||
| Q2 24 | — | 11.7% |
净利率BNTXXYL
| Q1 26 | — | 8.9% | ||
| Q4 25 | — | 14.0% | ||
| Q3 25 | -1.9% | 10.0% | ||
| Q2 25 | -148.2% | 9.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 14.5% | ||
| Q3 24 | 15.9% | 10.3% | ||
| Q2 24 | — | 8.9% |
每股收益（稀释后）BNTXXYL
| Q1 26 | — | $0.79 | ||
| Q4 25 | — | $1.37 | ||
| Q3 25 | — | $0.93 | ||
| Q2 25 | — | $0.93 | ||
| Q1 25 | — | $0.69 | ||
| Q4 24 | — | $1.33 | ||
| Q3 24 | — | $0.89 | ||
| Q2 24 | — | $0.80 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $808.0M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | — | $11.0B |
| 总资产 | — | $17.0B |
| 负债/权益比越低杠杆越低 | — | 0.18× |
8季度趋势，按日历期对齐
现金及短期投资BNTXXYL
| Q1 26 | — | $808.0M | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $989.0M | ||
| Q2 24 | — | $815.0M |
总债务BNTXXYL
| Q1 26 | — | $1.9B | ||
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益BNTXXYL
| Q1 26 | — | $11.0B | ||
| Q4 25 | — | $11.5B | ||
| Q3 25 | — | $11.2B | ||
| Q2 25 | — | $11.1B | ||
| Q1 25 | — | $10.8B | ||
| Q4 24 | — | $10.6B | ||
| Q3 24 | — | $10.6B | ||
| Q2 24 | — | $10.3B |
总资产BNTXXYL
| Q1 26 | — | $17.0B | ||
| Q4 25 | — | $17.6B | ||
| Q3 25 | — | $17.3B | ||
| Q2 25 | — | $17.2B | ||
| Q1 25 | — | $16.6B | ||
| Q4 24 | — | $16.5B | ||
| Q3 24 | — | $16.0B | ||
| Q2 24 | — | $15.8B |
负债/权益比BNTXXYL
| Q1 26 | — | 0.18× | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.18× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BNTX
暂无分部数据
XYL
| Revenue from products | $1.8B | 83% |
| Revenue from services | $368.0M | 17% |
